Agios Pharmaceuticals Retained Earnings (Accumulated Deficit) 2012-2024 | AGIO

Agios Pharmaceuticals retained earnings (accumulated deficit) from 2012 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Agios Pharmaceuticals Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-823
2022 $-471
2021 $-239
2020 $-1,843
2019 $-1,516
2018 $-1,105
2017 $-798
2016 $-483
2015 $-285
2014 $-167
2013 $-113
2012 $-74
2011 $
Agios Pharmaceuticals Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $-52
2024-06-30 $-1,000
2024-03-31 $-904
2023-12-31 $-823
2023-09-30 $-727
2023-06-30 $-635
2023-03-31 $-552
2022-12-31 $-471
2022-09-30 $-507
2022-06-30 $-425
2022-03-31 $-334
2021-12-31 $-239
2021-09-30 $-144
2021-06-30 $-55
2021-03-31 $31
2020-12-31 $-1,843
2020-09-30 $-1,746
2020-06-30 $-1,647
2020-03-31 $-1,556
2019-12-31 $-1,516
2019-09-30 $-1,414
2019-06-30 $-1,308
2019-03-31 $-1,198
2018-12-31 $-1,105
2018-09-30 $-1,013
2018-06-30 $-918
2018-03-31 $-849
2017-12-31 $-798
2017-09-30 $-710
2017-06-30 $-633
2017-03-31 $-550
2016-12-31 $-483
2016-09-30 $-427
2016-06-30 $-364
2016-03-31 $-308
2015-12-31 $-285
2015-09-30 $-244
2015-06-30 $-204
2015-03-31 $-172
2014-12-31 $-167
2014-09-30 $-140
2014-06-30 $-144
2014-03-31 $-126
2013-12-31 $-113
2013-09-30 $-101
2013-06-30 $-90
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.175B $0.027B
Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.249B 26.05
Stryker (SYK) United States $146.711B 33.06
Boston Scientific (BSX) United States $132.644B 38.14
EssilorLuxottica (ESLOY) France $112.106B 0.00
Medtronic (MDT) Ireland $110.562B 16.42
Haleon (HLN) United Kingdom $43.682B 28.38
Lonza Group Ag (LZAGY) Switzerland $42.166B 0.00
GE HealthCare Technologies (GEHC) United States $37.665B 19.54
ResMed (RMD) United States $35.786B 29.41
Terumo (TRUMY) Japan $29.739B 0.00
Koninklijke Philips (PHG) Netherlands $24.805B 18.99
Zimmer Biomet Holdings (ZBH) United States $21.942B 13.97
Insulet (PODD) United States $18.443B 73.44
Baxter (BAX) United States $16.957B 11.03
Smith & Nephew SNATS (SNN) United Kingdom $11.065B 0.00
BellRing Brands (BRBR) United States $10.158B 40.72
Bio-Rad Laboratories (BIO) United States $9.320B 31.68
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $6.294B 14.62
TG Therapeutics (TGTX) United States $5.459B 0.00
Haemonetics (HAE) United States $4.297B 20.97
Prestige Consumer Healthcare (PBH) United States $4.192B 20.85
ICU Medical (ICUI) United States $4.125B 39.27
Perrigo (PRGO) Ireland $3.830B 11.27
Envista Holdings (NVST) United States $3.697B 27.54
Neogen (NEOG) United States $3.246B 37.45
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.841B 18.22
QuidelOrtho (QDEL) United States $2.700B 17.38
LeMaitre Vascular (LMAT) United States $2.428B 59.00
Warby Parker (WRBY) United States $2.349B 0.00
Green Thumb Industries (GTBIF) United States $1.913B 33.48
AtriCure (ATRC) United States $1.742B 0.00
InMode (INMD) Israel $1.597B 9.61
AdaptHealth (AHCO) United States $1.326B 9.48
Maravai LifeSciences Holdings (MRVI) United States $1.318B 0.00
Curaleaf Holdings (CURLF) Canada $1.267B 0.00
BioLife Solutions (BLFS) United States $1.207B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.96
Owens & Minor (OMI) United States $0.952B 7.44
CeriBell (CBLL) United States $0.943B 0.00
National Vision Holdings (EYE) United States $0.918B 30.68
Capricor Therapeutics (CAPR) United States $0.847B 0.00
Evolus (EOLS) United States $0.798B 0.00
VAREX IMAGING (VREX) United States $0.684B 30.25
Omeros (OMER) United States $0.632B 0.00
Surmodics (SRDX) United States $0.563B 0.00
Cresco Labs (CRLBF) United States $0.533B 0.00
Verano Holdings (VRNOF) United States $0.522B 0.00
Canopy Growth (CGC) Canada $0.468B 0.00
Quanterix (QTRX) United States $0.451B 0.00
ZimVie (ZIMV) United States $0.391B 32.95
Valneva SE (VALN) France $0.360B 0.00
Viemed Healthcare (VMD) United States $0.341B 32.41
Cerus (CERS) United States $0.332B 0.00
Sanara MedTech (SMTI) United States $0.330B 0.00
Biote (BTMD) United States $0.325B 7.12
OraSure Technologies (OSUR) United States $0.289B 19.40
Zynex (ZYXI) United States $0.263B 55.07
Aurora Cannabis (ACB) Canada $0.238B 0.00
TerrAscend (TSNDF) Canada $0.225B 0.00
Utah Medical Products (UTMD) United States $0.221B 15.29
High Tide (HITI) Canada $0.213B 88.33
MacroGenics (MGNX) United States $0.203B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.167B 100.00
Organigram Holdings (OGI) Canada $0.166B 0.00
Jin Medical (ZJYL) China $0.164B 0.00
Zevia PBC (ZVIA) United States $0.160B 0.00
FitLife Brands (FTLF) United States $0.149B 18.67
TriSalus Life Sciences (TLSI) United States $0.138B 0.00
Fonar (FONR) United States $0.104B 11.74
Quipt Home Medical (QIPT) United States $0.104B 0.00
Veru (VERU) United States $0.099B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.40
Ayr Wellness (AYRWF) United States $0.077B 0.00
Rockwell Medical (RMTI) United States $0.073B 37.50
Exagen (XGN) United States $0.072B 0.00
Cellectar Biosciences (CLRB) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.062B 0.00
Modular Medical (MODD) United States $0.058B 0.00
MariMed (MRMD) United States $0.057B 0.00
Apyx Medical (APYX) United States $0.054B 0.00
Safety Shot (SHOT) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.019B 0.00
Meihua Medical Technologies (MHUA) China $0.018B 0.00
Innovative Eyewear (LUCY) United States $0.016B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.002B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.83
SNDL (SNDL) Canada $0.000B 0.00